Aemetis Net Worth
Aemetis Net Worth Breakdown | AMTX |
Aemetis Net Worth Analysis
Aemetis' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Aemetis' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Aemetis' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Aemetis' net worth analysis. One common approach is to calculate Aemetis' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Aemetis' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Aemetis' net worth. This approach calculates the present value of Aemetis' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Aemetis' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Aemetis' net worth. This involves comparing Aemetis' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Aemetis' net worth relative to its peers.
Enterprise Value |
|
To determine if Aemetis is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Aemetis' net worth research are outlined below:
| Aemetis is way too risky over 90 days horizon | |
| Aemetis appears to be risky and price may revert if volatility continues | |
| Aemetis has high likelihood to experience some financial distress in the next 2 years | |
| Aemetis currently holds 417.34 M in liabilities. Aemetis has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Aemetis' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 186.72 M. Net Loss for the year was (46.42 M) with loss before overhead, payroll, taxes, and interest of (5.54 M). | |
| Aemetis has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Aemetis Biogas Starts Production From Tenth Dairy Digester With Additional Digesters in Final ... |
Aemetis uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Aemetis. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Aemetis' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Aemetis' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Aemetis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aemetis backward and forwards among themselves. Aemetis' institutional investor refers to the entity that pools money to purchase Aemetis' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Susquehanna Fundamental Investments, Llc | 2024-06-30 | 126.1 K | Captrust Financial Advisors | 2024-09-30 | 121.2 K | Lpl Financial Corp | 2024-09-30 | 107.7 K | Group One Trading, Lp | 2024-09-30 | 101.4 K | Bridgeway Capital Management, Llc | 2024-09-30 | 99.9 K | Pnc Financial Services Group Inc | 2024-09-30 | 96.2 K | Goldman Sachs Group Inc | 2024-09-30 | 86.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 85.4 K | Nuveen Asset Management, Llc | 2024-09-30 | 78 K | Blackrock Inc | 2024-06-30 | 2.3 M | Vanguard Group Inc | 2024-09-30 | 2.1 M |
Follow Aemetis' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 153.18 M.Market Cap |
|
Project Aemetis' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.19) | (0.20) | |
| Return On Capital Employed | (0.24) | (0.25) | |
| Return On Assets | (0.19) | (0.20) | |
| Return On Equity | 0.21 | 0.22 |
When accessing Aemetis' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Aemetis' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Aemetis' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Aemetis' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Aemetis. Check Aemetis' Beneish M Score to see the likelihood of Aemetis' management manipulating its earnings.
Evaluate Aemetis' management efficiency
Aemetis has return on total asset (ROA) of (0.0855) % which means that it has lost $0.0855 on every $100 spent on assets. This is way below average. Aemetis' management efficiency ratios could be used to measure how well Aemetis manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 0.22 in 2024, whereas Return On Tangible Assets are likely to drop (0.20) in 2024. At this time, Aemetis' Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 38.2 M in 2024, despite the fact that Net Tangible Assets are likely to grow to (172.6 M).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (5.70) | (5.42) | |
| Tangible Book Value Per Share | (5.70) | (5.42) | |
| Enterprise Value Over EBITDA | (17.63) | (18.51) | |
| Price Book Value Ratio | (0.92) | (0.97) | |
| Enterprise Value Multiple | (17.63) | (18.51) | |
| Price Fair Value | (0.92) | (0.97) | |
| Enterprise Value | 342.8 M | 359.9 M |
Understanding the operational decisions made by Aemetis management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Enterprise Value Revenue 1.6253 | Revenue 291.4 M | Quarterly Revenue Growth 0.186 | Revenue Per Share 6.727 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aemetis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aemetis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aemetis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Aemetis Corporate Filings
F4 | 25th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
| 9th of August 2024 Other Reports | ViewVerify |
Aemetis Earnings per Share Projection vs Actual
Aemetis Corporate Executives
Elected by the shareholders, the Aemetis' board of directors comprises two types of representatives: Aemetis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aemetis. The board's role is to monitor Aemetis' management team and ensure that shareholders' interests are well served. Aemetis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aemetis' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Todd CPA | Executive CFO | Profile | |
| Todd Waltz | CFO, Executive VP and Secretary | Profile |
Already Invested in Aemetis?
The danger of trading Aemetis is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aemetis is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aemetis. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aemetis is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Aemetis Stock Analysis
When running Aemetis' price analysis, check to measure Aemetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aemetis is operating at the current time. Most of Aemetis' value examination focuses on studying past and present price action to predict the probability of Aemetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aemetis' price. Additionally, you may evaluate how the addition of Aemetis to your portfolios can decrease your overall portfolio volatility.